Skip to content
Research Article Open access CC BY 3.0

Two Novel Alkylating Structural Analogues of Chloramphenicol Suitable for Topical Treatment of Dermal Neoplasms

Ronald Bartzatt

Journal of Advances in Medical and Pharmaceutical Sciences · pp. 11–23 · Published 8 Jul 2014

10.9734/JAMPS/2014/11838

Abstract

Aims: To evaluate the efficacy of two alkylating structural analogues of chloramphenicol that have potential for application for treatment of dermal sited neoplasms. Study Design: Two compounds have been shown to alkylate guanosine-5’-diphosphate (GDP) at physiological conditions. These same compounds are evaluated for dermal penetration based on Kp and compared to other alkylating agents applied for treatment of skin cancer. Place and Duration of Study: University of Nebraska, Omaha Nebraska from December 2013 to May 2014 and March to August of 2002. Methodology: Two analogues of chloramphenicol were synthesized and shown to alkylate GDP at pH 7.4 and 37ºC. Various pharmacological properties of these two analogues, such as Log P, molecular weight, polar surface area, etc, were determined and compared.  The dermal permeability coefficient Kp was determined for two analogues based on their molecular weight and partition coefficient Log P. The numerical values of Kp were used to prediction of the distance each analogue is expected to travel in penetration of a dermal barrier. Result was plotted and compared to the anticancer agent’s carmustine, mustargen, and 5-fluorouracil. Evaluation of the analogues included findings of previous studies.   Results: Two analogues of chloramphenicol alkylate sites on GDP. The properties of compound 1 and compound 2 were determined and when compared to the parent structure chloramphenicol were found to have favorable drug likeness.  Values of Log P and permeability coefficient Kp for compounds 1 and 2 are; 3.343, 3.312, 0.00244 cm/hour, 0.000768 cm/hour, respectively.  Values of Kp for both compound 1 and 2 were greater than that of chloramphenicol at 0.000131 cm/hour. Plots of skin penetration showed compounds 1 and 2 to be superior to 5-fluorouracil. Conclusion: Analogues 1 and 2 were shown to have alkylation activity and properties suitable for drug likeness. Both compounds have high penetration rates of dermal layers.  

Chloramphenicol dermal neoplasm skin cancer nitrogen mustard

References (35)

  1. 1 Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1 [DOI]
  2. 2 Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings [DOI]
  3. 3 Harrison's Principles of Internal Medicine [DOI]
  4. 4 Incidence Estimate of Nonmelanoma Skin Cancer in the United States, 2006 [DOI]
  5. 5 Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans [DOI]
  6. 6 The Organic Chemistry of Drug Design and Drug Action [DOI]
  7. 7 Prevalence of a History of Skin Cancer in 2007 [DOI]
  8. 8 Early detection and treatment of skin cancer.
  9. 9 Current sunscreen controversies: a critical review [DOI]
  10. 10 Early detection and treatment of skin cancer
  11. 11 Topical Chemotherapy in Cutaneous T-cell Lymphoma [DOI]
  12. 12 Ultraviolet Radiation and Melanoma [DOI]
  13. 13 Sun Exposure, Sun Protection, and Vitamin D [DOI]
  14. 14 The Organic Chemistry of Drug Design and Drug Action [DOI]
  15. 15 Transdermal drug delivery: principles and opioid therapy [DOI]
  16. 16 Cutaneous T Cell Lymphoma: Update of Treatment [DOI]
  17. 17 Percutaneous dermal drug delivery for local pain control.
  18. 18 Malignant Skin Neoplasms [DOI]
  19. 19 Prevalence of a History of Skin Cancer in 2007: Results of an Incidence-Based Model [DOI]
  20. 20 Topical Treatment of Early Cutaneous T-cell Lymphoma [DOI]
  21. 21 Long term follow up of topical mustine treatment for cutaneous Langerhans cell histiocytosis [DOI]
  22. 22 Merkel cell carcinoma: a clinical, histopathologic, and immunohistochemical review [DOI]
  23. 23 Treatment of Early-Stage Mycosis Fungoides With Twice-Weekly Applications of Mechlorethamine and Topical Corticosteroids [DOI]
  24. 24 Medical approaches to non-melanoma skin cancer [DOI]
  25. 25 The Merck manual of diagnosis and therapy, 19th ed.
  26. 26 O6-alkylguanine-DNA alkyltransferase in cutaneous T-cell lymphoma: implications for treatment with alkylating agents.
  27. 27 The Merck Manual of Diagnosis and Therapy [DOI]
  28. 28 Treatment of Alopecia Areata with Topical Nitrogen Mustard [DOI]
  29. 29 Non-surgical treatments for skin cancer [DOI]
  30. 30 Treatment of cutaneous T-cell lymphoma.
  31. 31 Topical nitrogen mustard in the treatment of alopecia areata: a bilateral comparison study [DOI]
  32. 32 Two lead drug designs based on chloramphenicol as the parent structure, which express alkylation activity with potential for clinical applications [DOI]
  33. 33 The mathematics of diffusion [DOI]
  34. 34 Harrison's Principles of Internal Medicine. [DOI]
  35. 35 The Merck Manual of Diagnosis and Therapy [DOI]

Cited by 4

HSPiP and QbD oriented optimized green nanoemulsion to treat chloramphenicol contaminated water

Tasneem Khan, Aziya Khan, Afzal Hussain · Journal of Molecular Liquids · 2024

Showing 2 of 4 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

47

Page views

0

PDF downloads

19

Outbound clicks

4

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.